Additional hypotensive effect of endothelin-1 receptor antagonism in hypertensive dogs under angiotensin-converting enzyme inhibition.

Donckier, J E; Massart, P E; Hodeige, D; Van Mechelen, H; Clozel, J P; Laloux, O; Ketelslegers, J M; Charlier, A A; Heyndrickx, G R

Donckier, J E; Massart, P E; Hodeige, D; Van Mechelen, H; Clozel, J P; Laloux, O; Ketelslegers, J M; Charlier, A A; Heyndrickx, G R.

Affiliation

Donckier JE; Division of Endocrinology, University Hospital UCL of Mont-Godinne, Yvoir, Belgium.

Circulation ; 96(4): 1250-6, 1997 Aug 19.

Article in En | MEDLINE | ID: mdl-9286956

Subject(s)

Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Antihypertensive Agents/therapeutic use; Enalaprilat/therapeutic use; Endothelin Receptor Antagonists; Hypertension/drug therapy; Sulfonamides/therapeutic use; Animals; Antihypertensive Agents/blood; Antihypertensive Agents/pharmacology; Blood Pressure/drug effects; Bosentan; Dogs; Dose-Response Relationship, Drug; Endothelin-1; Sulfonamides/blood; Sulfonamides/pharmacology; Vascular Resistance/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sulfonamides / Angiotensin-Converting Enzyme Inhibitors / Enalaprilat / Endothelin Receptor Antagonists / Hypertension / Antihypertensive Agents Limits: Animals Language: En Journal: Circulation Year: 1997 Document type: Article

Search on Google

XML

PubMed Links